期刊文献+

泉州市2009年甲型H1N1流感疫苗集中接种工作质量评估

Quality Assessment on Vaccination of Influenza A(H1N1) Vaccine in Quanzhou City in 2009
原文传递
导出
摘要 目的评价泉州市2009年高中学生甲型H1N1流感(简称甲流)疫苗集中接种工作质量。方法对甲流疫苗集中接种前后的准备、接种率和发病情况进行分析。结果甲流疫苗集中接种质量控制严格;临时接种点设置规范,功能分区合理;疑似预防接种异常反应急救药械和临床医生配备齐全;严格执行接种后观察30 min。高中学生接种率为83.96%,异常反应发生率为2.37/10万。接种2周后高中学生发病率和发病构成比均明显下降(χ2=39.346,P<0.001;χ2=6.280,P<0.05),且未再出现暴发疫情。结论甲流疫苗具有良好的安全性和免疫原性。 Objective To evaluate the quality of massive vaccination of influenza A(H1N1) vaccine among high-school students in Quanzhou city in 2009.Methods The preparation for massive vaccination against influenza A(H1N1)was evaluated.Inoculation rates and incidence rates were analyzed.The data was analyzed by χ2 test with SPSS13.0.Results Vaccination quality was strictly controlled.Varied arrangements for vaccination were put in place.Temporary vaccination points were set in compliance with the standard,with reasonable functional division and complete first-aid pharmaceutical machinery for AEFI.Inoculation objects were observed 30 min after inoculation.Vaccination rate was 83.96% among high-school students.Abnormal reaction rate was 2.37/100 000.After 2 weeks of the inoculation,the incidence and constituent ratio of influenza A(H1N1)among high-school students were significantly lower than pre-inoculation(χ2=39.346,P0.001;χ2=6.280,P0.05),and outbreaks did not happen again.Conclusion Influenza A(H1N1) vaccine is effective and safe.
出处 《热带医学杂志》 CAS 2010年第11期1331-1332,共2页 Journal of Tropical Medicine
关键词 甲型H1N1流感疫苗 集中接种 质量评估 influenza A(H1N1) vaccine vaccination quality assessment
  • 相关文献

参考文献7

  • 1CDC.Use of influenza A/H1N1 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009[J]. MMWR Recomm Rep, 2009, 58 (RR 10) : 1-8.
  • 2CDC.Serum crossreactive antibody response to a novel influenza A/H1N1 virus after vaccination with seasonal influenza vaccine [J]. MMWR Morb Mortal Wkly Rep, 2009, 58(6) :521-524.
  • 3Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups [J]. N Engl J Med, 2009,361 (25) : 2414-2423.
  • 4庄茂欣,潘红星,王芙,崔颖杰,姜葳,张雪峰,孟繁岳,姚根红,周余春,胡小奎,朱凤才.甲型H1N1流感疫苗安全性和免疫原性初步研究[J].东南大学学报(医学版),2009,28(6):459-463. 被引量:8
  • 5WHO & WPRO. Immunization safety surveillance:guidelines for managers of immunization programs on reporting and investigating adverse enents following immunization IS]. Manila, Phillipines, 1999.
  • 6陶黎纳,胡家瑜,郑英杰.上海市2006年预防接种安全性分析[J].中国疫苗和免疫,2008,14(4):297-303. 被引量:55
  • 7张富斌,张振国,孙印旗,王丽娜,郝铃,李静,刘曙光.河北省2005~2007年疑似预防接种异常反应监测分析[J].中国疫苗和免疫,2008,14(6):538-542. 被引量:35

二级参考文献17

  • 1刘东磊,苗良,孙美平.北京市2002年预防接种后不良反应分析[J].中国计划免疫,2004,10(5):261-263. 被引量:30
  • 2郭飚,曹雷,曹玲生,徐立君,梁晓峰,张振国,罗耀星,孙印旗,彭国文,赵占杰.河北、广东省预防接种副反应监测试点培训效果评估[J].中国计划免疫,2005,11(4):302-305. 被引量:34
  • 3CDC. Update: swine influenza A/HIN1 infections-California and Texas, April 2009 [ J ]. MMWR Morb Mortal Wkly Rep, 2009,58:435-437.
  • 4CDC. Swine influenza A/H1N1 infection in two children- Southern California, March- April 2009 [ J ]. MMWR Morb Mortal Wkly Rep,2009,58:400-402.
  • 5World Health Organization. New influenza A/H1N1 virus: global epidemiological situation,June 2009[ J]. Wkly Epidemiol Rec ,2009,84:249-257.
  • 6CDC. Use of influenza A/H1N1 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices ( ACIP), 2009 [ J ]. MMWR Recomm Rep, 2009,58(RR- 10) :1-8.
  • 7CDC. Serum cross-reactive antibody response to a novel influenza A/H1N1 virus after vaccination with seasonal influenza vaccine[J]. MMWR Morb Mortal Wkly Rep,2009,58:521-524.
  • 8European Committee for Proprietary Medicinal Products. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application (CPMP/ VEG/ 4717/03). European Agency for the Evaluation of Medicinal Products[ EB/OL]. [ 2008- 12- 18 ]. http://www.emea. europa. eu/Ddfs/human/vwp/471703enfin. pdf.
  • 9Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines [ EB/OL ]. [ 2007- 05- 01 ]. http ://www. fda. gov/cber/guidelines.htm.
  • 10GREENBERG M E, LAI M H, HARTEL G F, et al. Response after one dose of a monovalent influenza A ( H1N1 ) 2009 vaccine-preliminary report [ J ]. N Engl J Med, 2009 [ Epub ahead of print].

共引文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部